OBJECTIVE: Microvascular malperfusion after myocardial infarction leads to infarct expansion, adverse remodeling, and functional impairment. Native reparative mechanisms exist but are inadequate to vascularize ischemic myocardium. We hypothesized that a 3-dimensional human fibroblast culture (3DFC) functions as a sustained source of angiogenic cytokines, thereby augmenting native angiogenesis and limiting adverse effects of myocardial ischemia. METHODS: Lewis rats underwent ligation of the left anterior descending coronary artery to induce heart failure; experimental animals received a 3DFC scaffold to the ischemic region. Border-zone tissue was analyzed for the presence of human fibroblast surface protein, vascular endothelial growth factor, and hepatocyte growth factor. Cardiac function was assessed with echocardiography and pressure-volume conductance. Hearts underwent immunohistochemical analysis of angiogenesis by co-localization of platelet endothelial cell adhesion molecule and alpha smooth muscle actin and by digital analysis of ventricular geometry. Microvascular angiography was performed with fluorescein-labeled lectin to assess perfusion. RESULTS: Immunoblotting confirmed the presence of human fibroblast surface protein in rats receiving 3DFC, indicating survival of transplanted cells. Increased expression of vascular endothelial growth factor and hepatocyte growth factor in experimental rats confirmed elution by the 3DFC. Microvasculature expressing platelet endothelial cell adhesion molecule/alpha smooth muscle actin was increased in infarct and border-zone regions of rats receiving 3DFC. Microvascular perfusion was also improved in infarct and border-zone regions in these rats. Rats receiving 3DFC had increased wall thickness, smaller infarct area, and smaller infarct fraction. Echocardiography and pressure-volume measurements showed that cardiac function was preserved in these rats. CONCLUSIONS: Application of a bioengineered 3DFC augments native angiogenesis through delivery of angiogenic cytokines to ischemic myocardium. This yields improved microvascular perfusion, limits infarct progression and adverse remodeling, and improves ventricular function. 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
OBJECTIVE:Microvascular malperfusion after myocardial infarction leads to infarct expansion, adverse remodeling, and functional impairment. Native reparative mechanisms exist but are inadequate to vascularize ischemic myocardium. We hypothesized that a 3-dimensional human fibroblast culture (3DFC) functions as a sustained source of angiogenic cytokines, thereby augmenting native angiogenesis and limiting adverse effects of myocardial ischemia. METHODS: Lewis rats underwent ligation of the left anterior descending coronary artery to induce heart failure; experimental animals received a 3DFC scaffold to the ischemic region. Border-zone tissue was analyzed for the presence of human fibroblast surface protein, vascular endothelial growth factor, and hepatocyte growth factor. Cardiac function was assessed with echocardiography and pressure-volume conductance. Hearts underwent immunohistochemical analysis of angiogenesis by co-localization of platelet endothelial cell adhesion molecule and alpha smooth muscle actin and by digital analysis of ventricular geometry. Microvascular angiography was performed with fluorescein-labeled lectin to assess perfusion. RESULTS: Immunoblotting confirmed the presence of human fibroblast surface protein in rats receiving 3DFC, indicating survival of transplanted cells. Increased expression of vascular endothelial growth factor and hepatocyte growth factor in experimental rats confirmed elution by the 3DFC. Microvasculature expressing platelet endothelial cell adhesion molecule/alpha smooth muscle actin was increased in infarct and border-zone regions of rats receiving 3DFC. Microvascular perfusion was also improved in infarct and border-zone regions in these rats. Rats receiving 3DFC had increased wall thickness, smaller infarct area, and smaller infarct fraction. Echocardiography and pressure-volume measurements showed that cardiac function was preserved in these rats. CONCLUSIONS: Application of a bioengineered 3DFC augments native angiogenesis through delivery of angiogenic cytokines to ischemic myocardium. This yields improved microvascular perfusion, limits infarct progression and adverse remodeling, and improves ventricular function. 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Authors: T D Henry; K Rocha-Singh; J M Isner; D J Kereiakes; F J Giordano; M Simons; D W Losordo; R C Hendel; R O Bonow; S M Eppler; T F Zioncheck; E B Holmgren; E R McCluskey Journal: Am Heart J Date: 2001-11 Impact factor: 4.749
Authors: Patrick I McConnell; Carlos L del Rio; Douglas B Jacoby; Martina Pavlicova; Pawel Kwiatkowski; Agatha Zawadzka; Jonathan H Dinsmore; Louis Astra; Sheik Wisel; Robert E Michler Journal: J Thorac Cardiovasc Surg Date: 2005-09-02 Impact factor: 5.209
Authors: Vasant Jayasankar; Y Joseph Woo; Timothy J Pirolli; Lawrence T Bish; Mark F Berry; Jeffrey Burdick; Timothy J Gardner; H Lee Sweeney Journal: J Card Surg Date: 2005 Jan-Feb Impact factor: 1.620
Authors: Juan J Gavira; Jesús Herreros; Ana Perez; María José Garcia-Velloso; Joaquín Barba; Francisco Martin-Herrero; Consuelo Cañizo; Ana Martin-Arnau; Josep M Martí-Climent; Milagros Hernández; Natalia López-Holgado; José María González-Santos; Cándido Martín-Luengo; Eduardo Alegria; Felipe Prósper Journal: J Thorac Cardiovasc Surg Date: 2006-04 Impact factor: 5.209
Authors: Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry Journal: Nat Biotechnol Date: 2007-08-26 Impact factor: 54.908
Authors: William Hiesinger; Matthew J Brukman; Ryan C McCormick; J Raymond Fitzpatrick; John R Frederick; Elaine C Yang; Jeffrey R Muenzer; Nicole A Marotta; Mark F Berry; Pavan Atluri; Y Joseph Woo Journal: J Thorac Cardiovasc Surg Date: 2012-01-20 Impact factor: 5.209
Authors: Jordan J Lancaster; Elizabeth Juneman; Sarah A Arnce; Nicholle M Johnson; Yexian Qin; Russell Witte; Hoang Thai; Robert S Kellar; Jose Ek Vitorin; Janis Burt; Mohamed A Gaballa; Joseph J Bahl; Steven Goldman Journal: J Heart Lung Transplant Date: 2013-12-17 Impact factor: 10.247
Authors: Tal Dvir; Michael Bauer; Avi Schroeder; Jonathan H Tsui; Daniel G Anderson; Robert Langer; Ronglih Liao; Daniel S Kohane Journal: Nano Lett Date: 2011-09-14 Impact factor: 11.189